Marshall Wace
CDLX icon

Marshall Wace’s Cardlytics CDLX Stock Holding History

Marshall Wace’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,590
Closed -$59.2K – 2940
2025
Q2 		$59.2K Buy
+3,590
New +$62K ﹤0.01% 2584
2025
Q1 		– Sell
-20,706
Closed -$768K – 2661
2024
Q4 		$768K Sell
20,706
-64,689
-76% -$2.48M ﹤0.01% 1855
2024
Q3 		$2.73M Buy
85,395
+3,967
+5% +$220K ﹤0.01% 1246
2024
Q2 		$6.69M Buy
81,428
+5,208
+7% +$563K 0.01% 891
2024
Q1 		$11M Buy
76,220
+13,885
+22% +$1.17M 0.02% 715
2023
Q4 		$5.74M Sell
62,335
-42,749
-41% -$4.35M 0.01% 866
2023
Q3 		$17.3M Sell
105,084
-7,455
-7% -$969K 0.04% 484
2023
Q2 		$7.11M Buy
112,539
+13,706
+14% +$830K 0.01% 880
2023
Q1 		$3.36M Buy
98,833
+76,928
+351% +$4.02M 0.01% 1188
2022
Q4 		$1.27M Buy
21,905
+735
+3% +$45.4K ﹤0.01% 1978
2022
Q3 		$1.99M Buy
21,170
+2,797
+15% +$398K ﹤0.01% 2020
2022
Q2 		$4.1M Buy
+18,373
New +$6.15M 0.01% 1489
2022
Q1 		– Sell
-2,066
Closed -$1.37M – 3402
2021
Q4 		$1.37M Buy
+2,066
New +$1.58M ﹤0.01% 2295
2021
Q3 		– Sell
-12,563
Closed -$15.9M – 3055
2021
Q2 		$15.9M Buy
12,563
+4,395
+54% +$4.96M 0.07% 303
2021
Q1 		$8.96M Buy
8,168
+5,896
+260% +$7.79M 0.04% 511
2020
Q4 		$3.24M Buy
+2,272
New +$2.42M 0.02% 736
2019
Q2 		– Sell
-2,033
Closed -$336K – 1397
2019
Q1 		$336K Buy
+2,033
New +$331K ﹤0.01% 1239

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Marshall Wace's CDLX Position: Q3 2025 in Review

Marshall Wace sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 3,590 shares — an estimated $59.2K sold.

Marshall Wace first reported a position in CDLX in Q1 2019 and held it in 17 quarters. The position peaked at $17.3M in Q3 2023. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • Marshall Wace reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 3,590 Cardlytics shares in Q3 2025, an estimated $59.2K.
  • Marshall Wace first reported a position in Cardlytics in Q1 2019 and held it in 17 quarters.
  • Marshall Wace's Cardlytics position peaked at $17.3M in Q3 2023.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.